The BSE Sensex has near key support at 75,150, below which a dip towards 74,400 seems likely. Technical chart shows the Nifty 50 index seems headed towards the 20-month moving average.
Zen Technologies share price: The company said it bagged new orders worth just Rs 1.69 crore in the December 2024 quarter (Q3FY25)
Donald Trump's reciprocal tariff plan on India and other countries coupled with persistent FII selling dragged the Sensex, Nifty lower for the eight straight trading session on Friday.
At 02:40 PM; the BSE Smallcap and BSE Midcap indices were down 3.1% and 2.3%, respectively, as against 0.3% decline in the BSE Sensex.
The apex court rejected a series of review petitions filed by Bharti Airtel and Vodafone Idea challenging its 2021 verdict
Concord Enviro share price hit a new low of Rs 523.05, down 20% on the BSE, after the company reported a consolidated net loss of Rs 8.56 crore in Q3FY25
Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.
Analysts at Elara Capital analysed market breadth cycles in India stock markets in the last few years and highlighted the worrying points that are developing for the first time in five years.
Senco Gold share price: The company's management said it is likely to achieve 7-8% Ebitda margin in Q4 going forward based on its brand positioning
TCPL Packaging share price: n the past one year, TCPL Packaging share has outperformed the market by surging 60 per cent
HCC posted a loss of Rs 216 crore in the December quarter of FY25, as against a profit of Rs 68.5 crore in the same quarter a year ago
Ashok Leyland's Ebitda margin expanded 80 basis points (bps) to 12.8 per cent in Q3FY25, up from 12 per cent in Q3FY24, surpassing Street estimates
PI Industries' steady Q3FY25 performance, cautious near-term outlook, and portfolio challenges are likely to affect the business dynamics in FY26 and FY27, according to analysts.
EBITDA for Q3FY25 was impacted by lower sales in export formulation biz, price reduction in the Electral range of products, driven by NLEM price revisions changes in the product mix, and higher cost.
The spike in Shilpa Medicare's stock price came after the company announced the approval of its Investigational New Drug (IND) - Nor Ursodeoxycholic Acid Tablets 500 mg, by CDSCO
Motilal Oswal sees decent visibility for loan and earnings growth, as well as continued progress on stressed asset resolutions
The management expects cement demand to grow on the back of likely increase in rural consumption aided by improved farm cash flows and sustained healthy demand for urban housing.
The uptick in HAL share price came after the company posted a healthy set of Q3FY25 results
In the past six months, the Nifty Metal index has underperformed the market by falling 6 per cent as against a 4 per cent decline in the benchmark index
Technical charts of Polycab India, Voltas, KEI Industries and Lodha show the formation of a bearish pattern, namely 'Death Cross' on the daily scale; hence these stocks may see further downside.